NCT04569708Withdrawn
Sleep Spindles and Memory in Rolandic Epilepsy
Auditory Stimulation Effect on Spindles and Sleep Dependent Learning in Rolandic Epilepsy
Source: ClinicalTrials.gov · Last updated 7 Aug 2026
Brief summary (registry, in English)
The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients.
- Status (registry)
- Withdrawn
- Study type
- Interventional
- Enrollment
- 0 (actual)
- First submitted
- 24 Sept 2020
- Start date
- 16 Jan 2021
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Epilepsy
- NCT number
- NCT04569708
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Has other unrelated neurological disease
- Unable to have an MRI/MEG due to claustrophobia, history of frequent vomiting, permanent metal in body (braces), or over MRI weight limit: 350lbs
Other
- Has abnormal brain MRI
Who the study is looking for
- Clinical diagnosis of childhood epilepsy with centrotemporal spikes (CECTS)or Rolandic epilepsy by child neurologist
- Ages 4-18 years
- Has an EEG with sleep activated centrotemporal spikes
- Has had at least 1 focal motor or generalized seizure
Age in the registry: 4 years to 18 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Athinoula A. Martinos Center Biomedical Imaging Coordinator of this site? Confirm its status | Charlestown | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.